Orion Group Holdings, Inc. ORN 深 滬
等待開盤 11-07 09:30:00 美东时间
10.29
-0.710
-6.45%
華盛通- 最 高11.04
- 今 開11.03
- 成交量 31.25万股
- 最 低 10.20
- 昨 收 11.00
- 總市值 4.09亿
- 52周最高 11.49
- 市盈率 靜 --
- 換手率 0.79%
- 52周最低 4.6402
- 委 比 -73.91%
- 總股本 3973.52万
- 歷史最高 13.77
- 量 比 0.57
- 振 幅 7.64%
- 歷史最低 1.53
- 每 手 1
- 風險率 1.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Orion Gr Hldgs Q3 Adj. EPS $0.09 Beats $0.06 Estimate, Sales $225.097M Beat $222.417M Estimate
Orion Gr Hldgs (NYSE:ORN) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.06 by 55.17 percent. This is a 43.75 percent decrease over earnings of $0.16 per share from the
10-29 04:18
Here are the major earnings after the close Tuesday
Major earnings expected after the bell on Tuesday include: Visa (V) W. P. Carey (WPC) Enphase Energy (ENPH) Expand Energy Corporation (EXE) ONEOK (OKE) Other earnings slated for release after Tuesday'...
10-28 22:00
Earnings Scheduled For October 28, 2025
Companies Reporting Before The Bell • PayPal Holdings (NASDAQ:PYPL) is expected...
10-28 19:11
Torrent Pharma Secures CCI Approval for J.B. Chemicals Acquisition
An update from Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ) is now availabl...
10-22 03:22
阿斯利康携四项重磅研究首发数据亮相ESMO，彰显重新定义癌症治疗的雄心
（来源：氨基观察） DESTINY-Breast11与DESTINY-Breast05两项研究入选主席研讨会（Presidential Symposium）...
10-15 12:05
阿斯利康将携四项重磅研究首发数据亮相欧洲肿瘤内科学会年会
来源：环球网 欧洲肿瘤内科学会（ESMO）年会将于2025年10月17日至21日召开。 本次大会上，阿斯利康将公布逾95项摘要，涵盖9款已获得批准药物及9款潜...
10-14 19:46
LED Lighting, EV Charging Station, and Maintenance Solutions Provider Orion Hosts Q2 Investor Call Wed., Nov. 5th at 10am ET
Orion Energy Systems, Inc., a provider of energy-efficient LED lighting, EV charging solutions, and electrical maintenance services, will host a conference call and webcast on November 5, 2025, at 10:00 a.m. ET to discuss its fiscal 2026 second quarter results. Participants must pre-register via the provided link to receive dial-in information. The webcast and replay will be available at the specified URL.
10-14 12:28
AstraZeneca Advances Ambition To Redefine Cancer Care With New Data Across Diverse Portfolio And Pipeline At ESMO Congress, October 17-21
Presidential Symposium will feature DESTINY-Breast11 and DESTINY-Breast05, underscoring potential of ENHERTU® (fam-trastuzumab deruxtecan-nxki) in HER2-positive early breast cancerTROPION-Breast02 data will
10-13 19:03
Orion Minerals Secures A$1.26 Million in New Share Placement
Orion Minerals Limited ( ($AU:ORN) ) just unveiled an announcement. Orion Miner...
10-10 08:18
Orion Minerals Strengthens Financial Position Through Share Issuance
Orion Minerals Limited ( ($AU:ORN) ) has issued an update. Orion Minerals Limit...
10-07 08:28
